> Safety can legitimately be in the backseat when you're trying to cure a disease that has a 50% chance to kill you in a year. Yes. Standards are lower in th

> Safety can legitimately be in the backseat when you're trying to cure a disease that has a 50% chance to kill you in a year. Yes. Standards are lower in that case. Back in the 1990s when I was up to date, clinical trials for HIV ad cancer treatments were truncated. We saw the rapid development of COVID vaccines recently, much quicker than normal drug development